Tapentadol also called Nucynta (Brand name) is a common medication (Know Tapentadol Market Insights) that is used to treat chronic pain and severe to acute pain. Today with the increasing number of increasing cases of chronic pain and musculoskeletal disorder has created an upswing in the demand of various pain killers present in the market. Tapentadol because of its effectiveness and low incidence of adverse effects has made it the most commonly prescribed medication for pain relief and market insight of this medication has now become an important point to look for by various pharmacies across the globe. Here we will be discussing various aspects related to Tapentadol Market Insights.
Tapentadol is an oral medication available in the market in 50 mg and 100mg variants. The global tapentadol market size is estimated to 3400 million in the year 2021 and is estimated to reach 4600 million by the year 2026. Some of the key players involved in the Tapentadol global market are johnson and Johnson, IPCA Laboratories Ltd, Lupin Laboratories Ltd, Aristo Pharmaceuticals Pvt. Ltd, Aktteva Biopharma LLP, Cadila Pharmaceuticals Ltd, Aristo Pharmaceuticals Pvt. Ltd.
Segmentation based on Application: The Tapentadol market can be divided into various categories based on the application some of the categories include cough treatment, pain management, Diabetic Neuropathic pain, and Cancer pain.
Segmentation based on end-user: Based on end-user, the Tapentadol market is divided into 3 major categories which are pharmacy, clinic, and Hospitals.
Segmentation based on Geography: The tapentadol market can be divided into various geographical regions where the demand for the medication is the main point of concern for the key market players of Tapentadol. The various main regions for the Tapentadol market include the USA, Brazil, Argentina, Canada, and Mexico across the American region. Under the Asia Pacific, the main region for the Tapentadol market is China, India, Japan, Malaysia, South Korea, and Thailand. European, Middle East, and African regions include France, Germany, Italy, Netherlands, Qatar, Saudi Arabia, and United Kingdoms.
Based on Product: Various variants of Tapentadol are available in the market on the basis of which we can analyze the Tapentadol market. Out of these different variants, 50mg and 100mg are the most common products to be concerned about.
This section refers to various developments in the field of medicine related to pain management or any event related to key players in the market. One of the recent events which can affect the Tapentadol market in the USA is the acquisition of Tapentadol manufacturer Assertion by the pharmaceutical company Collegium for USD 375 million. This recent event can affect the Tapentadol market.
Covid-19 is an ongoing global pandemic and an incomparable global health emergency which has affected each company in every sector especially the pharma sector where there is a sudden uprising in the demand for various medications. Tapentadol is one of the medications whose demand has been heavily impacted because of COVID-19. Various factors due to covid-19 that have impacted the tapentadol market are consumer behavior and demand, the impact of medicine supply due to lockdown situations in different regions, and intervention of government in pharma industries functioning. All these and various other factors have greatly affected the Tapentadol market in the previous years.